Jacobio Pharmaceuticals Group Co., Ltd. (HK:1167) has released an update.
Jacobio Pharmaceuticals Group Co., Ltd. has announced its intention to repurchase up to 10% of its issued shares, amounting to 79,175,508 shares, using up to HK$100 million of its own financial resources. This strategic move aims to enhance shareholder value by capitalizing on what the Board believes is the current undervaluation of the company’s shares in the market. The repurchase is subject to market conditions and will adhere to relevant regulations, with the company asserting a strong financial position and confidence in its long-term growth.
For further insights into HK:1167 stock, check out TipRanks’ Stock Analysis page.
